Contents © Peter Wittner, Interpharm Consultancy 2020
40 years’ experience of the European pharmaceutical industry in general and 35 years in generics in particular gives Interpharm the background to help you with whatever generic or biosimilar issues you may be facing.
Areas of Expertise
Whether you are thinking about:
- Generic Business Development
- Market intelligence and pricing data for generics and biosimilars
- Introducing your generic products into Europe or Israel
- Generic product out-
licensing in Europe, Israel or the United States - Planning some internal training (webinars, on-
site or podcasts) - Finding new products (see Generic Dossiers for details of dossiers available now)
- How to devise an effective defence strategy to protect your brands against generic competition
- Entering into the biosimilars market
- Bioequivalence studies for your generic developments
…………………please contact us.
Interpharm can also help with in-
A little bit of history…..
Interpharm Consultancy has been assisting companies in the generic pharmaceutical industry since 1997.
With a background of over 35 years in generics, I specialise in:-
- competitive generics and biosimilars intelligence
- advising on growth strategies or market entry strategies
- helping with business development
- training for new employees on understanding the generic marketplace, IP background and regulatory issues
- locating products and registration dossiers for EU companies
- providing a link between firms in the EU and companies based overseas who are trying to gain entry into this very competitive marketplace
- assisting branded companies to plan their defence strategies against generics
- offering help to companies looking for generic acquisitions
Please follow the link for some examples of previous projects
Interpharm has worked with a number of companies on a variety of generic-
When you want to know
about generics...
If you want to know about generic pharmaceuticals and biosimilars -
| Conferences and training |
| Article 01 - some thoughts about Podcasts |
| Generic Dossiers |
| Bioequivalence, Phase I-IV studies |